Softwr

Healthcare · head to head

Aidoc vs Ibex Medical Analytics

Aidoc logo

Aidoc

Healthcare

FDA cleared radiology AI for triage and notification of time critical findings

From
On request
Rated
-
Ibex Medical Analytics logo

Ibex Medical Analytics

Healthcare

Cancer detection AI for breast, prostate and gastric pathology deployed in routine clinical service, not just pilots

From
On request
Rated
-

The short version

  • Each has a real cost: Aidoc the clearances are for triage and notification in the CADt category, so the software may reorder a worklist but may not deliver a diagnosis or replace a read, and business cases built on reduced radiologist workload do not survive contact with the regulatory wording.; Ibex Medical Analytics the European IVDR indication is broader than the United States position, where some applications operate under laboratory developed test arrangements rather than FDA authorisation, which determines whether AI output can influence a signed report.
  • They diverge on capability: Aidoc covers Triage and notification, Ibex Medical Analytics covers Ibex Breast Suite.
  • Prices and features above were last checked on 1 September 2026.

Where they differ

Only the attributes on which Aidoc and Ibex Medical Analytics actually diverge.

Attributes where Aidoc and Ibex Medical Analytics differ
AttributeAidocIbex Medical Analytics
PlatformsWeb, iOS, AndroidWeb, Cloud, On-premise

Identical on both: starting price (On request), pricing model (quote), free tier (No), user rating (Not yet rated), category (Healthcare).

What each one covers

Drawn from each product's published feature list. An absence here means we hold no record of it - not that the product lacks it.

Only in Aidoc

  • Triage and notification
  • Intracranial haemorrhage
  • Pulmonary embolism
  • Large vessel occlusion
  • Pneumothorax on X-ray
  • aiOS platform
  • Clinical workflow notifications

Only in Ibex Medical Analytics

  • Ibex Breast Suite
  • Ibex Prostate
  • Ibex Gastric
  • Second read safety net
  • Prescreening triage
  • Heatmap localisation
  • Quality reporting
  • Scanner-agnostic ingestion

What people use each for

The jobs each tool is most often brought in to do.

Aidoc

  • A regional stroke centre that wants large vessel occlusion flagged and the neurointervention team notified before the radiologist dictatesnot Ibex Medical Analytics
  • A trauma centre wanting cervical spine fracture and intra abdominal free gas prioritised in an overnight queue read by one on call radiologistnot Ibex Medical Analytics
  • An oncology imaging programme that wants incidental pulmonary embolism caught on staging CTs ordered for a different questionnot Ibex Medical Analytics
  • A health system that has bought AI from several vendors and wants one PACS integration through aiOS rather than one integration per algorithmnot Ibex Medical Analytics

Ibex Medical Analytics

  • A histopathology department that cannot recruit and wants an automated safety net on every prostate and breast biopsy before sign outnot Aidoc
  • A private laboratory group standardising Gleason grading across pathologists with known interobserver variabilitynot Aidoc
  • A service digitising histopathology that needs a clinical governance argument to justify the scanning programme to its boardnot Aidoc
  • A gastrointestinal service wanting Helicobacter pylori detection automated so pathologists spend their time on the neoplastic casesnot Aidoc

Where each one falls short

Documented limitations, not opinions. Every one is a constraint you would hit in normal use.

Aidoc

  • The clearances are for triage and notification in the CADt category, so the software may reorder a worklist but may not deliver a diagnosis or replace a read, and business cases built on reduced radiologist workload do not survive contact with the regulatory wording.
  • Triage algorithms are tuned for sensitivity, so false positives are routine, and each one interrupts a radiologist. Sites that do not measure positive predictive value in their own case mix see clinician trust erode within months.
  • Pricing is per algorithm and per study volume with no published rate card, so the cost of a multi algorithm deployment escalates sharply and cannot be benchmarked before a sales conversation.
  • The clinical benefit accrues to stroke, trauma and cardiology service lines while the cost usually lands in the radiology or IT budget, which makes internal funding harder than the return on investment slides suggest.
  • Performance depends on scanner protocols and reconstruction settings, so results validated at one site do not transfer, and each deployment needs local validation work that is rarely budgeted for.

Ibex Medical Analytics

  • The European IVDR indication is broader than the United States position, where some applications operate under laboratory developed test arrangements rather than FDA authorisation, which determines whether AI output can influence a signed report.
  • It requires a fully digitised histopathology workflow, and slide scanning, storage and validation typically cost several times the algorithm licence.
  • Running it as a second read safety net adds a discrepancy resolution workload that departments consistently underestimate, and someone senior has to adjudicate every flag.
  • Coverage is limited to breast, prostate and gastric, so a general histopathology department still reads the majority of its case mix without any AI support.
  • Pricing is per case and unpublished, so cost scales directly with biopsy volume and does not flatten as the department grows.

Pricing, plan by plan

Aidoc

On request
  • Aidoc$undefined/year
    • Annual subscription priced by algorithm and by study volume
    • aiOS platform integration licensed separately from individual algorithms
    • Multi algorithm bundles negotiated for enterprise deployments

Ibex Medical Analytics

On request
  • Ibex clinical applications$undefined/year
    • Priced per case analysed under an annual agreement
    • Breast, prostate and gastric licensed as separate suites
    • Regulatory indication differs between Europe and the United States

Which should you pick?

Choose Aidoc if

  • You need triage and notification.
  • You work on Web, iOS, Android.
  • You also want intracranial haemorrhage.

Choose Ibex Medical Analytics if

  • You need ibex breast suite.
  • You work on Web, Cloud, On-premise.
  • You also want ibex prostate.

Questions people ask

Is Aidoc or Ibex Medical Analytics better?
Neither clearly leads. Aidoc starts at On request and Ibex Medical Analytics at On request, and user ratings are close enough to be indistinguishable. Choose on capability and platform support.
Which is cheaper, Aidoc or Ibex Medical Analytics?
Aidoc starts at On request and Ibex Medical Analytics at On request.
Does Aidoc or Ibex Medical Analytics run on more platforms?
Aidoc runs on Web, iOS, Android. Ibex Medical Analytics runs on Web, Cloud, On-premise.
What is Aidoc best used for?
Aidoc is most often used for a regional stroke centre that wants large vessel occlusion flagged and the neurointervention team notified before the radiologist dictates, a trauma centre wanting cervical spine fracture and intra abdominal free gas prioritised in an overnight queue read by one on call radiologist, an oncology imaging programme that wants incidental pulmonary embolism caught on staging cts ordered for a different question, a health system that has bought ai from several vendors and wants one pacs integration through aios rather than one integration per algorithm. Of those, a regional stroke centre that wants large vessel occlusion flagged and the neurointervention team notified before the radiologist dictates and a trauma centre wanting cervical spine fracture and intra abdominal free gas prioritised in an overnight queue read by one on call radiologist are not what Ibex Medical Analytics is typically brought in for.
What can Aidoc do that Ibex Medical Analytics cannot?
Aidoc covers Triage and notification, Intracranial haemorrhage, Pulmonary embolism, Large vessel occlusion. Ibex Medical Analytics covers Ibex Breast Suite, Ibex Prostate, Ibex Gastric, Second read safety net.

Answered from the vendors’ own pages

Aidoc: Is Aidoc FDA cleared?

Yes, it holds multiple 510(k) clearances, but they are for computer aided triage and notification. It may prioritise a worklist and notify a team. It may not provide a diagnostic interpretation or replace a radiologist read.

Ibex Medical Analytics: Is Ibex FDA cleared?

The regulatory position differs by product and market. In Europe the products carry CE marking under IVDR for defined diagnostic indications; in the United States some applications are used under laboratory developed test arrangements. Confirm the exact status for the specific application and market before assuming it can influence a signed report.

Aidoc: Does it reduce radiologist workload?

No. Every study still needs a full read. The benefit is in the order studies are read and how quickly a receiving specialty is activated, not in reading fewer studies.

Ibex Medical Analytics: Second read or prescreening?

Both are supported. Second read as a safety net is the more common clinical governance justification; prescreening is the efficiency case.

Aidoc: Can I run other vendors AI through it?

Yes, that is what the aiOS platform layer is for, and for health systems with several AI vendors it is often the main reason to buy Aidoc at all.

Ibex Medical Analytics: Does it need a particular scanner?

It ingests from the major whole slide scanner vendors rather than requiring a single fleet, which is a practical advantage over vendors tied to one scanner.

Aidoc: Is pricing published?

No. It is quoted per algorithm and by annual study volume, and enterprise bundles are negotiated case by case.

Ibex Medical Analytics: What tissue types are covered?

Breast, prostate and gastric. Everything else in the case mix is unsupported.

Share

Related pages

Other head to heads